What are Amylyx Pharmaceuticals, Inc.'s profit margins?

Amylyx Pharmaceuticals, Inc. (AMLX) runs a 100.0% gross margin and a -47349.8% operating margin, with a -45096.2% net margin.

Where do Amylyx Pharmaceuticals, Inc.'s ratios come from?

Every ratio is computed from Amylyx Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Amylyx Pharmaceuticals, Inc. AMLX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-63.3%+20.0pp	-61.6%+39.3pp	-56.5%+27.9pp	-87.4%-36.2pp	-83.2%-62.2pp
Return on assets	-58.5%+10.2pp	-55%+29.9pp	-48.7%+23.7pp	-71.2%-29.0pp	-68.7%-51.5pp
Return on invested capital	-165.3%-12.0pp	-176.3%+0.1pp	-129.9%+0.5pp	-129.1%-22.4pp	-153.3%-113pp
Liquidity
Current ratio	17.9×+5.8×	14.3×+7.6×	13.7×+9.2×	8.7×+4.1×	12.1×+7.6×
Quick ratio	17.9×+5.8×	14.3×+7.6×	13.7×+9.2×	8.7×+4.1×	12.1×+7.7×
Cash ratio	14.4×+11.0×	10×+7.3×	8.7×+7.4×	2.7×+1.6×	3.3×+1.5×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$2.47+5.1%	$3.23+33.5%	$3.56+23.4%	$1.88-51.0%	$2.35-50.8%
Valuation
Market capitalization	$1.54B+390%	$1.33B+412%	$1.45B+558%	$571.39M+343%	$313.65M+63.8%
Enterprise value	$1.31B+414%	$1.11B+502%	$1.23B+701%	$519.27M+810%	$255.27M+938%
Price / book	5.6×+4.1×	4.3×+2.8×	4.4×+3.2×	3.4×+2.9×	1.6×+1.0×
Earnings yield	-9.8%+60.0pp	-10.9%+106pp	-10.3%+107pp	-32.8%+95.8pp	-69.8%-32.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Amylyx Pharmaceuticals, Inc.'s profit margins?: Amylyx Pharmaceuticals, Inc. (AMLX) runs a 100.0% gross margin and a -47349.8% operating margin, with a -45096.2% net margin.
Where do Amylyx Pharmaceuticals, Inc.'s ratios come from?: Every ratio is computed from Amylyx Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.